Login / Signup

Heterogeneity of G6PD deficiency prevalence in Mozambique: a school-based cross-sectional survey in three different regions.

Beatriz GalatasLurdes MaboteWilson SimoneGloria MatambissoLidia NhamussuaMaría Del Mar Mañú-PereiraClara MenéndezFrancisco SauteEusebio MaceteQuique BassatPedro AlonsoPedro Aide
Published in: Malaria journal (2017)
These findings suggest that Mozambique, as a historically high malaria-endemic country has considerable levels of G6PD deficiency, that vary significantly across the country. This should be considered when planning national strategies for the use of licensed drugs that may be associated to haemolysis among G6PD individuals, or prior to the performance of future trials using primaquine and other 8-aminoquinolines derivatives. Registration Number CISM local ethics committee (CIBS-25/013, 4th of December 2013), and the National Ethics Committee of Mozambique (IRB00002657, 28th of February 2014).
Keyphrases
  • public health
  • quality improvement
  • big data
  • risk factors
  • replacement therapy
  • single cell
  • global health
  • artificial intelligence